Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mir S Adil

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biochemical Pharmacology|June 17, 2019
Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasisAbdulrahman Alwhaibi, Arti Verma, Sandeep Artham, et al.
Journal of Cellular Physiology|December 15, 2020
Distinct effects of pharmacological inhibition of stromelysin1 on endothelial-to-mesenchymal transition and myofibroblast differentiationAhlam Alharthi, Arti Verma, Harika Sabbineni, et al.
Journal of Cellular Physiology|February 24, 2021
Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infectionMir S Adil, Arti Verma, Madhuri Rudraraju, et al.
Journal of Basic and Clinical Pharmacy|August 1, 2015
Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care HospitalAmer Khan, Mir S Adil, K Nematullah, et al.
Cancers|April 12, 2022
Regulation of Let-7a-5p and miR-199a-5p Expression by Akt1 Modulates Prostate Cancer Epithelial-to-Mesenchymal Transition via the Transforming Growth Factor-β PathwayAbdulrahman Alwhaibi, Varun Parvathagiri, Arti Verma, et al.
Biochemical Pharmacology|April 3, 2020
PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodelingArti Verma, Sandeep Artham, Abdulrahman Alwhaibi, et al.
International Journal of Molecular Sciences|May 7, 2025
Claudin-17 Deficiency Drives Vascular Permeability and Inflammation Causing Lung InjuryMir S Adil, Varun Parvathagiri, Abdulaziz H Alanazi, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cellsSandeep Artham, Arti Verma, Abdulrahman Alwhaibi, et al.
Cells|June 10, 2022
Claudin-17 Deficiency in Mice Results in Kidney Injury Due to Electrolyte Imbalance and Oxidative StressMir S Adil, Varun Parvathagiri, Arti Verma, et al.
Journal of Clinical and Diagnostic Research : JCDR|December 18, 2015
EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care UnitMir S Adil, M Amer Khan, M Nematullah Khan, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|June 17, 2019
Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasisAbdulrahman Alwhaibi, Arti Verma, Sandeep Artham, et al.
Journal of Cellular Physiology|December 15, 2020
Distinct effects of pharmacological inhibition of stromelysin1 on endothelial-to-mesenchymal transition and myofibroblast differentiationAhlam Alharthi, Arti Verma, Harika Sabbineni, et al.
Journal of Cellular Physiology|February 24, 2021
Akt-independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS-CoV2 infectionMir S Adil, Arti Verma, Madhuri Rudraraju, et al.
Journal of Basic and Clinical Pharmacy|August 1, 2015
Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care HospitalAmer Khan, Mir S Adil, K Nematullah, et al.
Cancers|April 12, 2022
Regulation of Let-7a-5p and miR-199a-5p Expression by Akt1 Modulates Prostate Cancer Epithelial-to-Mesenchymal Transition via the Transforming Growth Factor-β PathwayAbdulrahman Alwhaibi, Varun Parvathagiri, Arti Verma, et al.
Biochemical Pharmacology|April 3, 2020
PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodelingArti Verma, Sandeep Artham, Abdulrahman Alwhaibi, et al.
International Journal of Molecular Sciences|May 7, 2025
Claudin-17 Deficiency Drives Vascular Permeability and Inflammation Causing Lung InjuryMir S Adil, Varun Parvathagiri, Abdulaziz H Alanazi, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cellsSandeep Artham, Arti Verma, Abdulrahman Alwhaibi, et al.
Cells|June 10, 2022
Claudin-17 Deficiency in Mice Results in Kidney Injury Due to Electrolyte Imbalance and Oxidative StressMir S Adil, Varun Parvathagiri, Arti Verma, et al.
Journal of Clinical and Diagnostic Research : JCDR|December 18, 2015
EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care UnitMir S Adil, M Amer Khan, M Nematullah Khan, et al.
Pageof 3